Central Chapter

Monday, July 2, 2018

Event date: 7/31/2018 6:30 PM - 8:00 PM Export event

A Novel Treatment Option for Distributive Shock (Non-CE Presentation)

John Devin, Pharm.D., FCCM, FCCP, BCCP

Critical Care Pharmacist and Clinical Scientist

Tufts Medical Center

Boston, MA

Tuesday, July 31, 2018 

Just Restaurant

2280 U.S. Hwy 9 South

Old Bridge, NJ 08857

(732) 707-4800

6:30 PM sign in (must pre-register)


  1. Describe the importance of maintaining a MAP > 65 mmHg in patients with distributive shock
  2. Distinguish the pharmacology and pharmacokinetics of angiotensin II with norepinephrine and vasopressin
  3. Describe the primary and secondary efficacy and safety results of the ATHOS-3 trial
  4. Develop a plan for the appropriate initiation and monitoring of angiotensin II in a patient with distributive/septic shock


This program is sponsored by: La Jolla Pharmaceuticals.

This is not an independent educational program, and no CME credits will be provided.



About the Central Chapter

The Central Chapter Membership includes members who either live or work in the counties of Hunterdon, Mercer, Middlesex, Monmouth, Ocean, and Somerset.

President: Maria Cardinale
President-Elect: Toral Patel
Secretary: Lawrence (Larry) Kaiserman
Treasurer: Alex Kardos

Central Chapter News

Beta Lactam Antibiotics and Skin Testing

NJSHP Central Chapter Meeting - 01/24/18

This lecture will describe the role of Penicillin Skin Test (PST) programs as a strategy to improve appropriate antimicrobial utilization by identifying patients that incorrectly report a penicillin allergy. It will raise awareness for the potential clinical and financial benefits and role of a well-structured PST program in the acute care setting by elaborating on the impact inappropriate antibiotic allergy documentation has on antibiotic selection. The lecture will also explain the signs and symptoms of a true anaphylactic allergy to a medication, and differentiate this from other reactions or side effects. It will also describe the process of performing, preparing, administering, and interpreting a penicillin skin test, and will highlight the roles that pharmacists and technicians can play in the development and implementation of a PST program. Lastly, the lecture will provide recommendations and strategies for implementation of a PST program within an acute care facility.

The Role of the Pharmacist in the Management of Chronic Obstructive Pulmonary Disease

NJSHP Central Chapter Meeting - 10/24/18

This program will review the role of the pharmacist in the management of COPD. Please join us as Dr. Fahim walks us through the pathophysiology of Chronic Obstructive Pulmonary Disorder (COPD), summarizes current treatment guidelines and identify emerging drug therapies for COPD, and discusses the pharmacist’s role in the management of COPD.